0001209191-19-059284.txt : 20191205 0001209191-19-059284.hdr.sgml : 20191205 20191205160701 ACCESSION NUMBER: 0001209191-19-059284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191203 FILED AS OF DATE: 20191205 DATE AS OF CHANGE: 20191205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwartz Eric CENTRAL INDEX KEY: 0001329100 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 191270499 MAIL ADDRESS: STREET 1: C/O ERESEARCHTECHNOLOGY, INC. STREET 2: 1818 MARKET STREET, SUITE 1000 CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-03 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001329100 Schwartz Eric 1100 CAMPUS ROAD PRINCETON NJ 08540 0 1 0 0 Corp VP, Gen Counsel & Sec Common Stock 2019-12-03 4 F 0 1515 60.49 D 35048 D Common Stock 2019-12-05 4 S 0 4007 61.6222 D 31041 D The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $61.58 to $61.69. /s/ Eric Schwartz 2019-12-05 EX-24 2 attachment1.htm EX-24 DOCUMENT







POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby authorizes Mythili
Seshan, Carol Shields and David Sirolly to execute for and on
behalf of the undersigned Forms 3, 4 and 5, and any amendments thereto, and
cause such form(s) to be filed with the United States Securities and Exchange
Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to
the undersigned's beneficial ownership of securities in Integra LifeSciences
Holdings Corporation (the "Company"). The undersigned also authorizes the above
persons to execute for and on behalf of the undersigned any Form ID or similar
document required to obtain or renew Securities and Exchange Commission
electronic filings codes and passwords and cause such form(s) to be submitted to
and/or filed with the Securities and Exchange Commission. The undersigned hereby
grants to each such attorney-in-fact full power and authority to do and perform
any and every act and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of the rights and powers herein granted, as fully to
all intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such capacity at the request
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

           This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys in-fact.

          IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 4th day of December 2019.


                                                        /s/ Eric Schwartz
                                                        Eric Schwartz